Absolute and relative overall CVD DALYs rate attributable to 1^st-level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Percentage distribution of DALYs for cardiovascular diseases in 2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Changes in crude fat, total FA, and FA profile from colostrum (1^st milking) to mature milk (13^th milking; n = 10). by Saman Lashkari (21440154)

Subjects:

Sex-specific and age-specific crude cumulative incidence and rate ratio of hemorrhagic stroke and CVST during the pre-pandemic (2007–2019) and pandemic (2020–2022) periods. by Soo Hyeon Cho (19797394)

Summary of time-series correlation analyses between hemorrhagic stroke & CVST and known risk factors during the pre-pandemic (2007–2019) and pandemic (2020–2022) periods. by Soo Hyeon Cho (19797394)

The difference of BMD between 2019 and 2022 classify by grop of urinary camium levels measured in 2019. by Aroon La-up (14095691)

Subjects:

Non-linear relationship between urinary cadmium and bone mineral density from the adjusted restricted cubic splines model. by Aroon La-up (14095691)

Subjects:

Prevalence of osteoporosis classified by sex, and urinary cadmium level compare between 2019 and 2022. by Aroon La-up (14095691)

Subjects:

Data. by Aroon La-up (14095691)

Subjects:

Stratified analysis of the association between urinary cadmium and bone mineral density, by sex. by Aroon La-up (14095691)

Subjects:

Characteristics of the study participants for continuous variables. by Aroon La-up (14095691)

Subjects:

summary of the confidence intervals. by Yohannis Derbew Molla (16471771)

Subjects:

Summary of Pooled Estimates and Heterogeneity for Key Variables. by Yohannis Derbew Molla (16471771)

Subjects:

PRISMA flowchart of the study selection process. by Yohannis Derbew Molla (16471771)

Subjects:

The proportional change in maximum height for the five study groups. by Teagan McMahon (20108036)

Subjects:

Regional differences in percentage changes of N05B prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N05C prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N06A prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Fer-1 alleviated liver lesions caused by <i>C. sinensis.</i> by Haoyang Zhang (1706815)

Subjects: